3M Purification has launched a new purification technology platform, under the 3M Emphaze brand, to help biopharmaceutical manufacturers achieve high product purity early in the manufacturing process, improving efficiency, and process economics.
The new 3M™ Emphaze™ AEX Hybrid Purifier uniquely combines three 3M core technologies that include advanced polymer materials, fine fibre nonwovens, and porous membranes into a novel purification media. The result is an all synthetic clarifying product line containing both a novel anion exchanges nonwoven media and a fine particle, bioburden reduction membrane, according to a press release.3M Purification has launched a new purification technology platform, under the 3M Emphaze brand, to help biopharmaceutical manufacturers achieve high #
Martin, global business manager, life sciences process technologies, 3M Purification said, “The 3M Emphaze AEX Hybrid Purifier is a multi-mechanism clarifying product. This, actually, represents a new class of clarifying products, with an all-synthetic construction, substantial anion exchange capacity, and a defined 0.2 µm pore size membrane.”
Greg Jellum, global laboratory manager, life sciences process technologies, 3M Purification said, “We designed the 3M Emphaze AEX Hybrid Purifier to provide the highest possible level of product protein purity early in biopharmaceutical downstream process. What is truly exciting is that by targeting the removal of particularly problematic impurities from entering the protein A column, a profound impact on the entire downstream process can be realized."
The 3M Emphaze AEX Hybrid Purifier offers a loading capacity similar to fine grades of highly-charged conventional depth filters, and can easily be incorporated into existing manufacturing processes where such a depth filter would be used. By providing the best possible protection of valuable downstream unit processes, the 3M Emphaze AEX Hybrid Purifier technology holds significant potential for improving efficiency in the production of mAb drugs, other mammalian or bacterial culture produced recombinant proteins or viral vectors, or plasma fractionation processes, the company said in a press release.
3M captures the spark of new ideas and transforms them into thousands of ingenious products. With US$31 billion in sales, 3M employs 89,000 people worldwide and has operations in more than 70 countries. (GK)
Fibre2fashion News Desk - India
News
Articles
Interviews
Webinars
Events
Advertise with us
About Us
Contact Us
Privacy Policy
Terms & Conditions
Cookie Policy
